Gabrielle Macaron, MD

home / authors / gabrielle-macaron-md

Staff neurologist, Cleveland Clinic; Hôtel-Dieu de France Hospital, Lebanon

Articles

Individualizing Disease-Modifying Therapy Selection in Newly Diagnosed MS: Gabrielle Macaron, MD

Gabrielle Macaron, MD;Isabella Ciccone, MPH

June 3rd 2025

The assistant professor in the Department of Neuroscience at Université de Montréal discussed key clinical factors influencing DMT selection in patients newly diagnosed with multiple sclerosis. [WATCH TIME: 5 minutes]

Clinical Pearls for MS Management in Everyday Practice

Gabrielle Macaron, MD

July 27th 2022

Dr Macaron shares her interpretation of the data and importance of individualizing treatment for patients with multiple sclerosis.

Ozanimod in DMT Naïve vs Experienced Patients with Relapsing Multiple Sclerosis

Gabrielle Macaron, MD

July 27th 2022

Dr Gabrielle Macaron reviews data with ozanimod in treatment naïve vs experienced patients with relapsing multiple sclerosis presented at EAN 2022.

Factors Necessitating Treatment Change in Multiple Sclerosis

Gabrielle Macaron, MD

July 27th 2022

A multiple sclerosis expert, Dr Gabrielle Macaron, discusses factors that can lead to a change of therapy for patients with multiple sclerosis.

Investigating Disability and Onset Age in NMOSD: Gabrielle Macaron, MD

Gabrielle Macaron, MD

February 10th 2021

The neurologist from Cleveland Clinic discussed how her study reinforced previous findings that individuals with early onset neuromyelitis optica spectrum disorders are more likely to experience severe vision loss.

Improving Outcomes in Patients With Early Onset NMOSD: Gabrielle Macaron, MD

Gabrielle Macaron, MD

January 27th 2021

The neurologist from Cleveland Clinic discussed how her team found that patients with AO ≤21 years old had worse visual outcomes than those >21 years old.